Overall and event-free survivals for acute lymphoblastic leukemia in children at a single institution in Taiwan

Hsi Che Liu, Shu Huey Chen, Kou Hwa Chang, Le Chiao Chiang, Chin Yueh Liu, Huei Lan Chang, Li Li Tsai, Der Cherng Liang

研究成果: 雜誌貢獻文章

7 引文 斯高帕斯(Scopus)

摘要

The results of treatment for childhood acute lymphoblastic leukemia (ALL) have improved dramatically over the past three decades. The authors present the long-term outcome of patients (n = 151) with ALL enrolled in 4 consecutive clinical trials conducted from 1982 to 1993 at Mackay Memorial Hospital. During this period, the backbone of the treatment remained relatively unchanged, including a 3- to 4-drug remission induction, central nervous system (CNS)-directed therapy, and cyclic pulses of vincristine and dexamethasone during maintenance therapy. More intensive therapy, consisting of reintensification and addition of more drugs during maintenance, was reserved for high-risk and very-high-risk paitents. The overall survival and event-free survival (± 1 SE) were 70 ± 4.1% and 64 ± 4.3%, respectively, with follow-up ranging from 7.6 to 18.7 years (median 12.2 year). The isolated CNS relapse rate was 4.3%. The dropout rate significantaly decreased from 35% in 1982-1984 to 0% in 1991-1993. Although the patient population is small, the overall results for childhood ALL at the authors' hospital are encouraging as compared to earlier reports in Taiwan.

原文英語
頁(從 - 到)19-29
頁數11
期刊Pediatric Hematology and Oncology
19
發行號1
DOIs
出版狀態已發佈 - 2002
對外發佈Yes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology
  • Cancer Research
  • Management of Technology and Innovation

指紋 深入研究「Overall and event-free survivals for acute lymphoblastic leukemia in children at a single institution in Taiwan」主題。共同形成了獨特的指紋。

  • 引用此